Standard-dose and high-dose biological drugs are associated with an increase in serious infections in rheumatoid arthritis, although low-dose biological drugs are not. The Lancet, 05/19/2015. (Also see Biologic Agents)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.